Follow the people · Insider
Awny Samaan Botros Farajallah
Awny Samaan Botros Farajallah files insider transactions with the SEC as a chief medical officer of Takeda Pharmaceutical Co (TAK). We hold 1 disclosed purchase or sale filed since 6 July 2026, 1 of them in the last 90 days.
- Files forTAK
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 July 2026 — 10 August 2026Chief Medical Officer · Takeda Pharmaceutical Co (TAK)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
2 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 14,006 shares of Takeda Pharmaceutical CoSEC Form 412 August 2026American Depositary Shares · traded 10 August 2026 · filed 12 August 2026
- was granted 17,554 shares of Takeda Pharmaceutical CoSEC Form 46 July 2026American Depositary Shares · traded 1 July 2026 · filed 6 July 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.